BioSpace News Archive

Bio NC

Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will deliver a company presentation at the 23rd Annual Needham Virtual Healthcare Conference on April 10, 2024 at 8:45 am ET.

April 3, 2024
·
1 min read
BioCapital

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

60 Degrees Pharmaceuticals, Inc. announced today that the Company will sponsor a pilot study of tafenoquine , the active molecule in its U.S. Food and Drug Administration (FDA)-approved human malaria prevention medication, ARAKODA®, for the treatment of babesiosis in dogs.

April 3, 2024
·
6 min read
Genetown

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

Collegium Pharmaceutical, Inc. today announced that management will participate in a fireside chat at the 23rd Annual Needham Healthcare Conference being held virtually from April 8-11, 2024.

April 3, 2024
·
1 min read
Job Trends

PixCell Medical Partners with Healthcare Giants Medline, Henry Schein, and Fisher Scientific to Distribute HemoScreen Point of Care CBC Analyzer Across the USA

PixCell Medical is pleased to announce a strategic distribution partnership with Medline, adding to the partnership agreements with Henry Schein and Thermo Fisher Scientific signed in recent months.

April 3, 2024
·
3 min read
Policy

Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro

Venus Concept Inc., a global medical aesthetic technology leader, announced that it has Therapeutic Goods Administration clearance in Australia to market the Venus Versa Pro system.

April 3, 2024
·
3 min read
Business

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2024 Financial Results

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Thursday, May 2, 2024 at 8:30 a.m. ET.

April 3, 2024
·
1 min read
Business

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CytomX Therapeutics, Inc. today announced the achievement of a second clinical candidate nomination under the companies’ TCB collaboration with Astellas, triggering a $5 million milestone payment to CytomX.

April 3, 2024
·
5 min read
Genetown

CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics today announced that members of its senior management team will present at the Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 11:45 a.m. ET.

April 3, 2024
·
1 min read
Drug Development

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

Aligos Therapeutics, Inc. today announced that dosing in the Phase 2a HERALD study of ALG-055009 has been initiated in subjects with metabolic dysfunction-associated steatohepatitis (MASH).

April 3, 2024
·
5 min read
Business

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

Tevogen Bio Holdings Inc announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development.

April 3, 2024
·
2 min read